National Institutes of Health
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional) is a funding opportunity from National Institutes of Health, closing September 7, 2026.
Sep 7, 2026
(38d left)